Vecuronium

Vecuronium Bromide Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.

Molecular Formula: C₃₄H₅₇BrN₂O₄

InChI: InChI=1/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-;/m0./s1/fC34H57N2O4.Br/h;1h/qm;-1

InChIKey: InChIKey=VEPSYABRBFXYIB-UIZXJRRODF
SMILES: CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]

Names:
    Bromure de vecuronium [INN-French]
    Bromuro de vecuronio [INN-Spanish]
    EINECS 256-723-9
    NC-45
    Norcuron
    ORG NC 45
    Vecuronii bromidum [INN-Latin]
    Vecuronium bromide [USAN:BAN:INN:JAN]
    VECURONIUM BROMIDE
    Vecuronium
    [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide

Registries:
    PubChem CID 39764
    PubChem ID 180739